-:沿?

Joshua E Reuss1, Samuel Rosner2, Benjamin P Levy3

  • 1Georgetown Lombardi Comprehensive Cancer Center, Washington, DC.

概括

抗体 - 药物合物 (ADC) 通过提供向的细胞毒性有效载荷,为高级非小细胞肺癌 (NSCLC) 提供了一种新的策略. 需要进一步的研究,以充分了解它们的机制,优化使用,并管理NSCLC治疗中的毒性.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K